MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Clinical trials for MULTI-DRUG RESISTANT NEPHROTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MULTI-DRUG RESISTANT NEPHROTIC SYNDROME trials appear
Sign up with your email to follow new studies for MULTI-DRUG RESISTANT NEPHROTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental CAR-T therapy targets lupus and kidney disease in new trial
Disease control Recruiting nowThis early-stage study tests a new treatment called QT-219C, which uses specially engineered immune cells (CAR-T cells) to target and destroy faulty B cells that drive autoimmune diseases like lupus, kidney disease, and scleroderma. The treatment is given as a one-time infusion a…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Engineered immune cells aim to tame autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment called QT-219CX, which uses specially engineered immune cells (CAR-T cells) to target and calm the overactive immune system in people with autoimmune diseases like lupus, kidney disease, and scleroderma. The treatment is given as a one-time infusi…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC
-
Immune cell therapy trial aims to tame childhood autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new treatment using specially engineered immune cells (CAR-NK cells) in 36 children with B cell-related autoimmune diseases like lupus and IgA nephropathy. The goal is to see if the therapy is safe and can control disease activity. Participants rece…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 05, 2026 12:05 UTC
-
Engineered immune cells take on lupus and kidney disease in new trial
Disease control Recruiting nowThis early-stage study is testing a universal donor CAR T-cell therapy that targets two proteins (CD19 and BCMA) on immune cells that drive autoimmune diseases. The goal is to see if it is safe and can help control conditions like lupus, kidney disease, and vasculitis. About 15 p…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC